RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ONCY
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Oncolytics Biotech Inc. stock after gaining 2.02%
(Updated on Jul 03, 2024)

Sell candidate since Jun 27, 2024 PDF

The Oncolytics Biotech Inc. stock price gained 2.02% on the last trading day (Wednesday, 3rd Jul 2024), rising from $0.99 to $1.01. During the last trading day the stock fluctuated 3.00% from a day low at $1.00 to a day high of $1.03. The price has been going up and down for this period, and there has been a -0.98% loss for the last 2 weeks. Volume fell on the last day by -82 thousand shares and in total, 98 thousand shares were bought and sold for approximately $99.19 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.98 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.28% during the next 3 months and, with a 90% probability hold a price between $0.88 and $1.04 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ONCY Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 28, 2024, and so far it has risen 2.02%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oncolytics Biotech Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.06. On a fall, the stock will find some support from the short-term average at $1.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Oncolytics Biotech Inc. stock

Oncolytics Biotech Inc. finds support from accumulated volume at $1.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.0300 between high and low, or 3.00%. For the last week the stock has had daily average volatility of 3.11%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ONCY) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Oncolytics Biotech Inc. to open at $1.01, and during the day (based on 14 day Average True Range), to move between $0.97 and $1.05, which gives a possible trading interval of +/-$0.0389 (+/-3.85%) up or down from last closing price. If Oncolytics Biotech Inc. takes out the full calculated possible swing range there will be an estimated 7.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.02 (0.99%) than the support at $1.00 (1.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Oncolytics Biotech Inc. stock A Buy?

Oncolytics Biotech Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.720 Sell Candidate Unchanged

Predicted Opening Price for Oncolytics Biotech Inc. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$1.01 ( 0.330%) $1.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ONCY

Fibonacci Support & Resistance Levels

Level Price
R3 1.04 3.30%
R2 1.03 2.17%
R1 1.02 1.46%
Price 1.01
S1 1.00 -0.80%
S2 0.99 -1.51%
S3 0.98 -2.64%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.15 13.86%
R2 1.06 4.95%
R1 1.02 0.99%
Price 1.01
S1 1.00 -1.43%
S2 1.00 -1.47%
S3 0.99 -1.98%

FAQ

What is the symbol for Oncolytics Biotech Inc. Stock and on which exchange is it traded?
The symbol for Oncolytics Biotech Inc. is ONCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Oncolytics Biotech Inc. Stock?
Oncolytics Biotech Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Oncolytics Biotech Inc. Stock?
Oncolytics Biotech Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oncolytics Biotech Inc. Stock.

What's the current price of Oncolytics Biotech Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an Oncolytics Biotech Inc. (ONCY) share was $1.01.

What is the 52-week high and low for Oncolytics Biotech Inc. Stock?
The 52-week high for Oncolytics Biotech Inc. Stock is $3.37 and the 52-week low is $0.89.

What is the market capitalization of Oncolytics Biotech Inc. Stock?
As of the Jul 03, 2024, the market capitalization of Oncolytics Biotech Inc. is 76.612M.

When is the next earnings date for Oncolytics Biotech Inc.?
The upcoming earnings date for Oncolytics Biotech Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Oncolytics Biotech Inc.

Oncolytics Biotech. Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with ... ONCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT